News Quantified

MASI – masimo corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Masimo (NASDAQ:MASI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.

Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.

Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

Masimo (NASDAQ:MASI) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.

-7.1%

BEAT

-11.7%

BEAT

-4.4%

BEAT

12.3%

BEAT

Wells Fargo & Company

Needham & Company LLC

Form 144 MASIMO CORP Filed by: Tripodi Blair

Form 8-K MASIMO CORP For: Dec 03

Form 8-K MASIMO CORP For: Dec 01

Form 144 MASIMO CORP Filed by: Ahmed Omar

Form 4 MASIMO CORP For: Nov 13 Filed by: Ahmed Omar

Top News Gainers

3/2 Masimo Announces FDA Clearance of Continuous RRp® Monitoring 9.0%

3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic 4.2%

3/12 Form 4 MASIMO CORP For: Mar 10 Filed by: KIANI JOE E 4.1%

8/6 Masimo Co. (NASDAQ: MASI) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 3.8%

4/24 Form 4 MASIMO CORP For: Apr 22 Filed by: KIANI JOE E 3.0%

6/7 Form 4 MASIMO CORP For: Jun 05 Filed by: Muhsin Bilal 3.0%

8/14 Form 4 MASIMO CORP For: Aug 12 Filed by: Lee Yongsam 3.0%

5/16 Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution 3.0%

6/3 Form 4 MASIMO CORP For: May 30 Filed by: Cohen H Michael 2.6%

1/17 Form 4 MASIMO CORP For: Jan 16 Filed by: Young Micah W 2.3%

Top News Decliners

5/6 Q1/2019 3/30/2019 EPS 0.790 ZacksConsensus 0.750 ActVsEst 0.040 - Beat -6.9%

3/19 Masimo Announces Agreement to Acquire TNI medical AG -5.5%

4/28 Masimo Corp (MASI) CEO Joe Kiani on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -5.4%

9/9 Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3® -5.3%

10/30 Form 10-Q MASIMO CORP For: Sep 28 -4.2%

3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic -4.1%

4/16 Masimo and Samsung Partner to Package Masimo SafetyNet™ with Select Samsung Phones to Speed COVID-19 Response Efforts -3.7%

8/2 Form 4 MASIMO CORP For: Jul 31 Filed by: KIANI JOE E -3.3%

7/31 Form 8-K MASIMO CORP For: Jul 31 -3.2%

2/20 Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at UBS Group AG from $190.00 to $207.00. They now have a "buy" rating on the stock. -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day